 John Campana
Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Flaps | 2 | 2014 | 142 | 0.360 |
Why?
| | Pectoralis Muscles | 1 | 2009 | 18 | 0.300 |
Why?
| | Neck | 1 | 2009 | 108 | 0.290 |
Why?
| | Skin Transplantation | 1 | 2009 | 85 | 0.290 |
Why?
| | Head | 1 | 2009 | 120 | 0.270 |
Why?
| | Graft Survival | 1 | 2009 | 510 | 0.250 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2007 | 643 | 0.240 |
Why?
| | Mouth | 1 | 2006 | 88 | 0.230 |
Why?
| | Mouth Neoplasms | 1 | 2006 | 90 | 0.220 |
Why?
| | Adenoma, Pleomorphic | 1 | 2005 | 9 | 0.220 |
Why?
| | Parotid Neoplasms | 1 | 2005 | 15 | 0.220 |
Why?
| | Head and Neck Neoplasms | 3 | 2021 | 562 | 0.200 |
Why?
| | Cranial Nerve Injuries | 1 | 2023 | 5 | 0.190 |
Why?
| | Carotid Body Tumor | 1 | 2023 | 5 | 0.190 |
Why?
| | Carcinoma | 1 | 2005 | 224 | 0.190 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2005 | 337 | 0.190 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2021 | 1143 | 0.180 |
Why?
| | Surgery, Plastic | 2 | 2006 | 53 | 0.150 |
Why?
| | Immunotherapy | 1 | 2021 | 659 | 0.120 |
Why?
| | Implantable Neurostimulators | 1 | 2016 | 10 | 0.120 |
Why?
| | Hypoglossal Nerve | 1 | 2016 | 10 | 0.120 |
Why?
| | Electric Stimulation Therapy | 1 | 2016 | 62 | 0.110 |
Why?
| | Prosthesis Implantation | 1 | 2016 | 153 | 0.110 |
Why?
| | Cobalt Radioisotopes | 1 | 2014 | 7 | 0.110 |
Why?
| | Skull Neoplasms | 1 | 2014 | 21 | 0.100 |
Why?
| | Chondrosarcoma | 1 | 2014 | 17 | 0.100 |
Why?
| | Lymphatic Metastasis | 2 | 2006 | 330 | 0.100 |
Why?
| | Facial Bones | 1 | 2014 | 28 | 0.100 |
Why?
| | Nasal Septal Perforation | 1 | 2014 | 5 | 0.100 |
Why?
| | Orbital Neoplasms | 1 | 2014 | 27 | 0.100 |
Why?
| | Nasal Septum | 1 | 2014 | 30 | 0.100 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2014 | 99 | 0.100 |
Why?
| | Face | 1 | 1994 | 174 | 0.090 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2016 | 300 | 0.090 |
Why?
| | Endoscopy | 1 | 2014 | 314 | 0.080 |
Why?
| | Neoplasm Invasiveness | 2 | 2014 | 503 | 0.070 |
Why?
| | Necrosis | 1 | 2009 | 243 | 0.070 |
Why?
| | Treatment Outcome | 4 | 2023 | 11713 | 0.060 |
Why?
| | Oral Surgical Procedures | 1 | 2006 | 4 | 0.060 |
Why?
| | Quinazolines | 1 | 2007 | 266 | 0.060 |
Why?
| | Mouth Mucosa | 1 | 2006 | 87 | 0.060 |
Why?
| | Brachytherapy | 1 | 2006 | 133 | 0.050 |
Why?
| | Frozen Sections | 1 | 2005 | 24 | 0.050 |
Why?
| | Lymph Node Excision | 1 | 2006 | 173 | 0.050 |
Why?
| | Neoplasm Staging | 2 | 2006 | 1460 | 0.050 |
Why?
| | Spinal Neoplasms | 1 | 2003 | 37 | 0.050 |
Why?
| | Keratins | 1 | 2003 | 170 | 0.050 |
Why?
| | Morbidity | 1 | 2023 | 322 | 0.040 |
Why?
| | Phototherapy | 1 | 2021 | 48 | 0.040 |
Why?
| | Biopsy | 1 | 2005 | 1078 | 0.040 |
Why?
| | Cetuximab | 1 | 2021 | 111 | 0.040 |
Why?
| | Survival Rate | 1 | 2006 | 2081 | 0.040 |
Why?
| | Humans | 11 | 2023 | 144298 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2023 | 17104 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2005 | 1501 | 0.040 |
Why?
| | Vascular Surgical Procedures | 1 | 2023 | 342 | 0.040 |
Why?
| | Female | 6 | 2016 | 78137 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2917 | 0.030 |
Why?
| | Postoperative Complications | 1 | 2009 | 2939 | 0.030 |
Why?
| | Aged | 4 | 2016 | 25901 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2007 | 2194 | 0.030 |
Why?
| | Male | 6 | 2016 | 72263 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2016 | 5404 | 0.030 |
Why?
| | Dermatofibrosarcoma | 1 | 1994 | 7 | 0.030 |
Why?
| | Fibrous Dysplasia of Bone | 1 | 2014 | 5 | 0.030 |
Why?
| | Facial Neoplasms | 1 | 1994 | 19 | 0.030 |
Why?
| | Cell Dedifferentiation | 1 | 2014 | 32 | 0.030 |
Why?
| | Retinal Neoplasms | 1 | 2014 | 37 | 0.030 |
Why?
| | Retinoblastoma | 1 | 2014 | 42 | 0.030 |
Why?
| | Facial Expression | 1 | 1994 | 73 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2014 | 305 | 0.020 |
Why?
| | Muscles | 1 | 1994 | 332 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1955 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2016 | 1098 | 0.020 |
Why?
| | Pain Measurement | 1 | 2014 | 553 | 0.020 |
Why?
| | Preoperative Care | 1 | 2014 | 378 | 0.020 |
Why?
| | Middle Aged | 4 | 2016 | 35892 | 0.020 |
Why?
| | Adult | 4 | 2016 | 40408 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2014 | 706 | 0.020 |
Why?
| | Cisplatin | 1 | 2007 | 336 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2007 | 1263 | 0.010 |
Why?
| | Risk Assessment | 1 | 2014 | 3680 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2741 | 0.010 |
Why?
| | Prospective Studies | 1 | 2016 | 7972 | 0.010 |
Why?
| | Culture Techniques | 1 | 2003 | 66 | 0.010 |
Why?
| | Mucin-1 | 1 | 2003 | 21 | 0.010 |
Why?
| | Cohort Studies | 1 | 2014 | 5948 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3879 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2003 | 688 | 0.010 |
Why?
| | Infant | 1 | 2014 | 10011 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2003 | 1699 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 14092 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1501 | 0.010 |
Why?
|
|
Campana's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|